Netherbeck

About Netherbeck

This author has not yet filled in any details.
So far Netherbeck has created 27 blog entries.

Introducing Menu Based Conjoint To The IDR Medical Service Portfolio

At IDR Medical, we work with our clients to launch new products from idea generation and concept development to market testing, pricing and launch strategy.

 We utilise a range of qualitative and quantitative research approaches including Conjoint Analysis.  Existing conjoint approaches are valuable to identify optimal product feature sets and pricing strategy, however, the complexity [...]

April 2nd, 2012|News|

Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery

Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts. The acquisition is subject to customary closing conditions. Pluromed has developed a proprietary polymer technology, called Rapid Transition Polymers (RTP(TM)), pioneering the use of injectable [...]

March 19th, 2012|News|

iBGStar Blood Glucose Meter Attachment For The iPhone

At the meeting of Association for the Study of Diabetes (EASD) in Stockholm, Sweden, Sanofi-aventis announced the world’s first attachment to iPhone and iPod that is a standalone medical device. The plug-in iBGStar was developed by Sanofi-aventis and AgaMatrix. The iBGStar device not only relies on the iPhone to perform computational functions and display results, [...]

January 2nd, 2012|News|

Strategies In Response to Low-Cost Medical Device Vendors

Driven by the global squeeze on healthcare expenditure, low-cost medical device vendors are making significant in-roads on maturing med-tech markets. Over recent years medical device brands, previously dismissed as low quality by hospital decision makers, are not only making regular appearances on hospital tenders but are winning those tenders.  A select group of low-cost medical [...]

January 2nd, 2012|News|

Physio Control Sold to Bain Capital – Medtronic Announces

Physio Control President Brian Webster, who will become CEO under Bain's ownership, said the sale means Physio "will be definitely adding staff in the short term" in a few areas like finance that were previously handled by Medtronic. The company has 650 workers in Redmond and 400 more worldwide, plus nearly 200 contract employees. In [...]

November 17th, 2011|News|

Atrium Medical has signed definitive agreement to be acquired by MAQUET Cardiovascular

"The acquisition of Atrium is an excellent strategic fit with our long-term business goals as Atrium's robust product line complements MAQUET Cardiovascular's existing therapy options and provides additional solutions for the customers that we serve," said Christian Keller, president and chief executive officer of MAQUET Cardiovascular.  "Like MAQUET, innovation is at the core of Atrium's business [...]

October 4th, 2011|News|

Cardiac Dimensions wins CE mark approval for its Carillon Mitral Contour System

Cardiac Dimensions has received the CE mark approval for its Carillon Mitral Contour System to treat heart failure patients suffering from functional mitral regurgitation (FMR). The Mitral Contour System combines a proprietary, implantable device with a percutaneous catheter delivery system.  The implantable device consists of a proximal anchor and a distal anchor connected by a [...]

September 30th, 2011|News|

Ethicon Endo-Surgery to acquire SterilMed

Ethicon Endo-Surgery is rumoured to acquire SterilMed. SterilMed provides products and services including pre-owned equipment sales, equipment repair, and medical device reprocessing which aid healthcare providers to lower their medical device and equipment costs and reduce the amount of environmental waste they generate. The acquisition allows SterilMed to be a part of the Ethicon Endo-Surgery [...]

September 29th, 2011|News|

FDA Approval For Melafind

MELA Sciences MELA today announced that the U.S. Food and Drug Administration (FDA) has issued an Approvable Letter for the MelaFind(R) Pre-Market Approval (PMA) application. The company intends to work with the agency to finalize the physician and patient labeling, package insert, user's guide, training program and clinical protocol for a post-approval study in order [...]

September 27th, 2011|News|

Drug Device Combinations at IDR Medical

Drug device combinations represent a growing focus of our business at IDR Medical. Our projects in this area typically involve understanding market requirements for innovative drug delivery platforms and testing the design, ergonomics and human factors associated with concept devices. As the point-of-care for drug therapy sees a shift from the clinic and hospital setting [...]

September 27th, 2011|News|